Upexi, Inc. logo

Upexi, Inc.

UPXI

NASDAQCommunication ServicesInternet Content & Information

Previous close

$1.08

+$0.1467 · +15.72%

Aug 21, 4:00 PM ET

UPXI company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Strong Sell

Exit — multiple negative signals converging

Valuation

2

Overpriced

Momentum

17

Strong Down

Sentiment

43

Mixed

Risk resilience

37

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.

Industry
Internet Content & Information
Sector
Communication Services
Headquarters
US
CEO
Allan Marshall
Listed since
Jun 23, 2021
Employees
59

Market position

Day range

Current $1.08

52-week range

Current $1.08

Open
$0.9515
Previous close
$0.9333
Volume
6.54M
2.82× average
Average volume
2.32M
Average daily volume
Market cap
79.33M USD
Beta
-0.24
Market reference 1
50-day average
$0.8444
+27.90% above average
200-day average
$1.4408
-25.04% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
48.39M USD
EV / EBITDA
-3.99×
Earnings yield
-58.02%
Free cash flow yield
-37.36%

Profitability & efficiency

Return on equity
-15.19%
Return on assets
-11.05%
Return on invested capital
-10.60%

Financial health

Current ratio
1.74×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends85%21%-43%-107%Gross margin, FY2021: 49.38%Gross margin, FY2022: 64.47%Gross margin, FY2023: 57.68%Gross margin, FY2024: 49.32%Gross margin, FY2025: 68.74%Operating margin, FY2021: 5.92%Operating margin, FY2022: -28.13%Operating margin, FY2023: -33.70%Operating margin, FY2024: -86.39%Operating margin, FY2025: -79.06%Net margin, FY2021: 12.36%Net margin, FY2022: -9.11%Net margin, FY2023: -46.46%Net margin, FY2024: -90.99%Net margin, FY2025: -86.55%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 49.38%. Gross margin FY2022 64.47%. Gross margin FY2023 57.68%. Gross margin FY2024 49.32%. Gross margin FY2025 68.74%. Operating margin FY2021 5.92%. Operating margin FY2022 -28.13%. Operating margin FY2023 -33.70%. Operating margin FY2024 -86.39%. Operating margin FY2025 -79.06%. Net margin FY2021 12.36%. Net margin FY2022 -9.11%. Net margin FY2023 -46.46%. Net margin FY2024 -90.99%. Net margin FY2025 -86.55%.

Income trends

Revenue

15.81M USD-39.19%

Operating income

−12.5M USD+44.35%

Net income

−13.68M USD+42.16%
Income trends across reported periods42.45M USD18.41M USD−5.63M USD−29.67M USDRevenue, FY2021: 24.1M USDRevenue, FY2022: 23.07M USDRevenue, FY2023: 36.44M USDRevenue, FY2024: 26M USDRevenue, FY2025: 15.81M USDOperating income, FY2021: 1.43M USDOperating income, FY2022: −6.49M USDOperating income, FY2023: −12.28M USDOperating income, FY2024: −22.46M USDOperating income, FY2025: −12.5M USDNet income, FY2021: 2.98M USDNet income, FY2022: −2.1M USDNet income, FY2023: −16.93M USDNet income, FY2024: −23.66M USDNet income, FY2025: −13.68M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 24.1M USD. Revenue FY2022 23.07M USD. Revenue FY2023 36.44M USD. Revenue FY2024 26M USD. Revenue FY2025 15.81M USD. Operating income FY2021 1.43M USD. Operating income FY2022 −6.49M USD. Operating income FY2023 −12.28M USD. Operating income FY2024 −22.46M USD. Operating income FY2025 −12.5M USD. Net income FY2021 2.98M USD. Net income FY2022 −2.1M USD. Net income FY2023 −16.93M USD. Net income FY2024 −23.66M USD. Net income FY2025 −13.68M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue15.81M USD26M USD36.44M USD23.07M USD24.1M USD
Cost of goods sold4.94M USD13.18M USD15.42M USD8.2M USD12.2M USD
Gross profit10.87M USD12.82M USD21.02M USD14.87M USD11.9M USD
Selling, general, and administrative22.99M USD22.54M USD26.07M USD19.8M USD9.44M USD
Operating expenses23.37M USD35.29M USD33.3M USD21.36M USD10.47M USD
Interest expense1.17M USD3.12M USD4.72M USD202.12K USD530.45K USD
Depreciation and amortization757.76K USD3.68M USD3.48M USD2.73M USD1.03M USD
Operating income−12.5M USD−22.46M USD−12.28M USD−6.49M USD1.43M USD
Net income−13.68M USD−23.66M USD−16.93M USD−2.1M USD2.98M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
20%
2 beats, 8 misses, 0 met estimates
Average EPS surprise
-650.72%
10 comparable reports
Latest EPS result
-1.67
Estimate -0.2 · Miss by 735.00%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.25-0.89-2.04-3.18Q1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26EstimateQ3 '26Estimate
Q1 2025, reported Feb 14, 2025: actual -1.24, estimate -1.6, surprise +22.50%, Beat. Q2 2025, reported May 16, 2025: actual -2.87, estimate -1.6, surprise -79.38%, Miss. Q3 2025, reported Sep 24, 2025: actual -0.24, estimate -0.065, surprise -269.23%, Miss. Q4 2025, reported Nov 11, 2025: actual -0.12, estimate 0.01, surprise -1300.00%, Miss. Q1 2026, reported Feb 10, 2026: actual -2.94, estimate -0.075, surprise -3820.00%, Miss. Q2 2026, reported May 12, 2026: actual -1.67, estimate -0.2, surprise -735.00%, Miss. Q3 2026, reported Sep 2, 2026: actual —, estimate -0.12, surprise —, Comparison unavailable. Q3 2026, reported Sep 24, 2026: actual —, estimate -0.12, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates19.31M13.7M8.08M2.47MQ1 '25MissQ2 '25MissQ3 '25MissQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26EstimateQ3 '26Estimate
Q1 2025, reported Feb 14, 2025: actual 4.01M USD, estimate 17.22M USD, surprise -76.74%, Miss. Q2 2025, reported May 16, 2025: actual 3.18M USD, estimate 18.1M USD, surprise -82.43%, Miss. Q3 2025, reported Sep 24, 2025: actual 3.3M USD, estimate 4.02M USD, surprise -17.93%, Miss. Q4 2025, reported Nov 11, 2025: actual 9.24M USD, estimate 9.16M USD, surprise +0.91%, Beat. Q1 2026, reported Feb 10, 2026: actual 2.91M USD, estimate 6.67M USD, surprise -56.40%, Miss. Q2 2026, reported May 12, 2026: actual 4.56M USD, estimate 2.9M USD, surprise +57.14%, Beat. Q3 2026, reported Sep 2, 2026: actual —, estimate 5.1M USD, surprise —, Comparison unavailable. Q3 2026, reported Sep 24, 2026: actual —, estimate 5.1M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$5.00

362.96% upside
Past 12 months12-month forecast

Price history unavailable

High $8.00Average $5.00Low $2.00

Rating distribution

4 ratings

Limited analyst sample: 4 ratings. Interpret the distribution with caution.

Strong buy00%
Buy375%
Hold125%
Sell00%
Strong sell00%

UPXI news

UPXI peers

ETFs holding UPXI

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research UPXI

research.disclaimer